Search results
Results From The WOW.Com Content Network
A vial of Covaxin used at a private hospital in Bengaluru, India. On 6 December 2020, Bharat Biotech applied to the Drugs Controller General of India (DCGI), seeking emergency use authorisation. [60] It was the third firm after Serum Institute of India and Pfizer to apply under such provision. [61]
Production of antibiotics is a naturally occurring event, that thanks to advances in science can now be replicated and improved upon in laboratory settings. Due to the discovery of penicillin by Alexander Fleming, and the efforts of Florey and Chain in 1938, large-scale, pharmaceutical production of antibiotics has been made possible.
Bebtelovimab is a neutralizing human immunoglobulin G1 (IgG1) monoclonal antibody, isolated from a patient who has recovered from the Coronavirus disease 2019 (COVID-19), directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19.
The first cases of COVID-19 in India were reported on 30 January 2020 in three towns of Kerala, among three Indian medical students who had returned from Wuhan, the epicenter of the pandemic. [10] [11] [12] Lockdowns were announced in Kerala on 23 March, and in the rest of the country on 25 March. Infection rates started to drop in September. [13]
On 20 July, with Latin America now being the epicentre of the pandemic, the WHO expressed concern at COVID-19's impact on indigenous people in the Americas. [ 115 ] On 23 July, as global cases topped 15 million, the Director-General of the WHO urged people to play their part in preventing the further spread of the pandemic, warning of no return ...
The government launched several initiatives to address these shortages, including converting public buildings into COVID-19 care centers and increasing domestic production of medical supplies. Unfortunately, the second wave of COVID-19 hit India in April 2021, resulting in even higher numbers of cases and deaths than the first wave.
The COVID-19 pandemic led to a significant disruption in healthcare, with an increase in the use of antibiotics during the treatment of viral infections. This rise in antibiotic prescribing, coupled with overwhelmed healthcare systems, contributed to a resurgence in AMR during the pandemic years.
A May 2020 poll concluded that 54% of people in the U.S. felt the federal government was doing a poor job in stopping the spread of COVID-19 in the country. 57% felt the federal government was not doing enough to address the limited availability of COVID-19 testing. 58% felt the federal government was not doing enough to prevent a second wave ...